Form 4: Roivant Sciences Director Melissa Epperly Receives Future Share Award Under Compensation Plan

Roivant Sciences Ltd. Director Melissa B. Epperly was awarded 1,609 common shares, effective July 17, 2025, as part of the company's Non-Employee Director Compensation Plan, increasing her total beneficial ownership to 42,985 shares.

Summary

• Melissa B. Epperly, a Director of Roivant Sciences Ltd. (ROIV), was awarded 1,609 common shares.
• The shares were received pursuant to the Issuer's Non-Employee Director Compensation Plan.
• The award was fully vested as of the grant date.
• The transaction date for this award is listed as July 17, 2025, indicating a pre-planned future transaction.
• Following this transaction, Ms. Epperly will beneficially own 42,985 common shares of Roivant Sciences Ltd.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The filing reports a routine equity compensation award to a director, which is a neutral event in terms of company performance but positively aligns director interests with shareholders. The future transaction date under a 10b5-1 plan indicates pre-planning and transparency.

Positives

• The award of shares to a director aligns their interests with those of the company's shareholders.
• The shares were fully vested as of the grant date, providing immediate ownership upon the transaction date.

Negatives

• No direct negative financial implications are apparent from this routine compensation award.

Future Outlook

The filing indicates a pre-planned transaction for July 17, 2025, under a Rule 10b5-1 plan, reflecting ongoing director compensation practices and the company's commitment to aligning director incentives with shareholder value.

Industry Context

This is a routine insider transaction filing, common across all industries, reflecting standard equity compensation practices for non-employee directors in publicly traded companies.

Corporate Governance

Related Party Transactions

• An award of 1,609 common shares to Melissa B. Epperly, a Director of Roivant Sciences Ltd., under the company's Non-Employee Director Compensation Plan, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The award aligns the director's interests with shareholders by increasing her equity stake in the company.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Key Dates

Keywords

Roivant Sciences, ROIV, SEC Form 4, Insider Trading, Director Compensation, Share Award, Equity Compensation, Melissa B. Epperly, Common Shares, 10b5-1 Plan